reSET-o

Showing 1 posts of 1 posts found.

fda2outsideweb

FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics

December 11, 2018
Manufacturing and Production, Sales and Marketing FDA, Novartis, Pear Therapeutics, app, opioid crisis, opioid epidemic, opioids, pharma, reSET-o

A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app …

Latest content